Skip to main content

and
Your search also matched 4 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Potentiation of antitumor effect of NKT cell ligand, α-galactosylceramide by combination with IL-12 on lung metastasis of malignant melanoma cells1

Include preview-only content
  1. Article

    Open Access

    Effect of immunosuppressants on a mouse model of osteogenesis imperfecta type V harboring a heterozygous Ifitm5 c.-14C > T mutation

    Osteogenesis imperfecta (OI) type V is an autosomal dominant disorder caused by the c.-14C > T mutation in the interferon-induced transmembrane protein 5 gene (IFITM5), however, its onset mechanism remains unclea...

    Nobutaka Hanagata, Taro Takemura, Keiko Kamimura, Toshiaki Koda in Scientific Reports (2020)

  2. Article

    Open Access

    Neu-medullocytes, sialidase-positive B cells in the thymus, express autoimmune regulator (AIRE)

    Neu-medullocytes, which were previously identified and named by our group, are sialidase (neuraminidase)-positive B cells that express immunoglobulin and Mac-1 in the mouse thymus. Recently, B cells that migra...

    Shigeko Kijimoto-Ochiai, Keiko Kamimura, Toshiaki Koda in Scientific Reports (2019)

  3. Article

    Open Access

    Absence of BRINP1 in mice causes increase of hippocampal neurogenesis and behavioral alterations relevant to human psychiatric disorders

    We have previously identified BRINP (BMP/RA-inducible neural-specific protein-1, 2, 3) family genes that possess the ability to suppress cell cycle progression in neural stem cells. Of the three family members...

    Miwako Kobayashi, Toshiyuki Nakatani, Toshiaki Koda, Ken-ichi Matsumoto in Molecular Brain (2014)

  4. Article

    The critical role of Th1-dominant immunity in tumor immunology

     To investigate the precise role of antigen-specific Th1 and Th2 cells in tumor immunity, we developed a novel adoptive tumor-immunotherapy model using OVA-specific Th1 and Th2 cells and an OVA gene-transfecte...

    Takashi Nishimura, Minoru Nakui, Marimo Sato in Cancer Chemotherapy and Pharmacology (2000)